(A–B’) Expression of JNKDN in scrib−/−
RasV12 clones inhibits caspase activity (A,A’; CC3) and ROS generation (B,B’; DHE). Scale bars: 50 μm. (C–K’) pJNK labeling (red in (C–K); grey in (C’–K’)) as JNK marker in scrib−/−
RasV12 (C,C’), JNKDN-expressing scrib−/−
RasV12 (D,D’) and ROS-depleted or caspase-inhibited scrib−/−
RasV12 mosaic discs (E–K’). The strong pJNK labeling in (C,C’) is significantly reduced in (D–K’). Scale bars: 50 μm. (L) The mean intensity of pJNK labelings in scrib−/−
RasV12 clones in panels (C’–K’) is significantly reduced upon ROS-depletion or reduction of caspase activity. Analysis of JNK labelings was done by one-way ANOVA with Holm-Sidak test for multiple comparisons. Error bars are SD. P values are referenced to scrib−/−
RasV12 and are indicated by asterisks above each column. ****p<0.0001. At least ten discs per genotype were analyzed. Genotypes: (A,B,D) yw ey-FLP/UAS-JNKDN; act>y+>Gal4, UAS-GFP56ST/+; FRT82B tub-Gal80/UAS-RasV12 FRT82B scrib2; (C) yw ey-FLP/+; act>y+>Gal4, UAS-GFP56ST/+; FRT82B tub-Gal80/UAS-RasV12 FRT82B scrib2; (E–K) yw ey-FLP/+; act>y+>Gal4, UAS-GFP56ST/UAS-X; FRT82B tub-Gal80/UAS-RasV12 FRT82B scrib2 with UAS-X being UAS-droncRNAi (E), UAS-drICERNAi (F), UAS-p35 (G), UAS-DuoxRNAi (H), UAS-hCatS (I), UAS-Catalase (J) and UAS-SOD2 (K).